Perspective Therapeutics (Acquired) Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 80

Employees

  • Latest Deal Type
  • M&A

Perspective Therapeutics (Acquired) General Information

Description

Developer of a radiopharmaceutical company intended to treat cancer. The company's pipeline of oncology therapeutics, diagnostic imaging agents, and lead (Pb)-212-based alpha-particle radiotherapies are designed to deliver powerful alpha radiation specifically to cancer cells with specialized targeting peptides, enabling health professionals to utilize the same targeting peptide for the purpose of personalizing treatment and optimizing patient outcomes.

Contact Information

Formerly Known As
Viewpoint Molecular Targeting
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 2401 Elliott Avenue
  • Suite 320
  • Seattle, WA 98121
  • United States
+1 (206)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 2401 Elliott Avenue
  • Suite 320
  • Seattle, WA 98121
  • United States
+1 (206)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Perspective Therapeutics (Acquired) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 07-Feb-2023 Completed Clinical Trials - Phase 1
7. Grant 31-Aug-2022 Completed Generating Revenue
6. Later Stage VC (Series A) 14-Jan-2021 Completed Generating Revenue
5. Grant 07-Sep-2020 Completed Generating Revenue
4. Grant 20-Sep-2019 Completed Generating Revenue
3. Grant 08-Sep-2017 Completed Generating Revenue
2. Grant 19-Jan-2017 $1.02M Completed Startup
1. Grant 31-Aug-2016 $1.2M Completed Startup
To view Perspective Therapeutics (Acquired)’s complete valuation and funding history, request access »

Perspective Therapeutics (Acquired) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a radiopharmaceutical company intended to treat cancer. The company's pipeline of oncology therapeutics, di
Drug Discovery
Seattle, WA
80 As of 2023

Seattle, WA
 

Houston, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Perspective Therapeutics (Acquired) Competitors (3)

One of Perspective Therapeutics (Acquired)’s 3 competitors is Perspective Therapeutics, a Formerly VC-backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Perspective Therapeutics Formerly VC-backed Seattle, WA
RadioMedix Venture Capital-Backed Houston, TX
RefleXion (Biotechnology) Venture Capital-Backed Hayward, CA
You’re viewing 3 of 3 competitors. Get the full list »

Perspective Therapeutics (Acquired) Patents

Perspective Therapeutics (Acquired) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240091705-A1 Removal of free-unlabeled cationic and anionic solution phase radionuclides from radiopharmaceuticals using solid-phase extraction techniques Pending 16-Sep-2022

Perspective Therapeutics (Acquired) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Perspective Therapeutics (Acquired) Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Iowa Economic Development Authority Government
Iowa Seed Fund Venture Capital Minority
NIH Seed Not-For-Profit Venture Capital
National Cancer Institute Government
National Institutes of Health Government
You’re viewing 5 of 8 investors. Get the full list »

Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Isoray Medical (Brachytherapy Business Division) Coralville, IA

Perspective Therapeutics (Acquired) FAQs

  • When was Perspective Therapeutics (Acquired) founded?

    Perspective Therapeutics (Acquired) was founded in 2015.

  • Where is Perspective Therapeutics (Acquired) headquartered?

    Perspective Therapeutics (Acquired) is headquartered in Seattle, WA.

  • What is the size of Perspective Therapeutics (Acquired)?

    Perspective Therapeutics (Acquired) has 80 total employees.

  • What industry is Perspective Therapeutics (Acquired) in?

    Perspective Therapeutics (Acquired)’s primary industry is Drug Discovery.

  • Is Perspective Therapeutics (Acquired) a private or public company?

    Perspective Therapeutics (Acquired) is a Private company.

  • What is Perspective Therapeutics (Acquired)’s current revenue?

    The current revenue for Perspective Therapeutics (Acquired) is .

  • How much funding has Perspective Therapeutics (Acquired) raised over time?

    Perspective Therapeutics (Acquired) has raised $14.3M.

  • Who are Perspective Therapeutics (Acquired)’s investors?

    Iowa Economic Development Authority, Iowa Seed Fund, NIH Seed, National Cancer Institute, and National Institutes of Health are 5 of 8 investors who have invested in Perspective Therapeutics (Acquired).

  • Who are Perspective Therapeutics (Acquired)’s competitors?

    Perspective Therapeutics, RadioMedix, and RefleXion (Biotechnology) are competitors of Perspective Therapeutics (Acquired).

  • When was Perspective Therapeutics (Acquired) acquired?

    Perspective Therapeutics (Acquired) was acquired on 07-Feb-2023.

  • Who acquired Perspective Therapeutics (Acquired)?

    Perspective Therapeutics (Acquired) was acquired by Perspective Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »